Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net loss	$ (6,199,990)	$ (5,255,597)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	119,557	79,799
Stock-based compensation	665,496	537,809
Amortization of discounts and premiums on short-term investments		(41,003)
Non-cash lease expense	58,335	53,886
Change in assets and liabilities:
Accounts receivable	(555,639)	(180,715)
Inventory	415,013	(469,769)
Prepaid expenses	(144,031)	(74,054)
Accounts payable	76,899	(24,862)
Accrued expenses, deferred revenue, operating leases and other liabilities	(420,194)	(1,669,283)
Net cash used in operating activities	(5,984,554)	(7,043,789)
Investing activities
Purchases of short-term investments		(1,473,419)
Maturities of short-term investments		3,500,000
Purchase of property and equipment	(68,491)	(187,206)
Net cash (used in) provided by investing activities	(68,491)	1,839,375
Financing activities
Proceeds from issuance of common stock attributed to equity financings	3,350,467	928,257
Issuance costs related equity financings	(160,406)	(183,359)
Share repurchases for the payment of employee taxes	(24,854)	(98,650)
Net cash provided by financing activities	3,165,207	646,248
Net decrease in cash and cash equivalents	(2,887,838)	(4,558,166)
Cash and cash equivalents at beginning of period	5,322,493	8,160,329
Cash and cash equivalents at end of period	2,434,655	3,602,163
Supplemental non-cash financing and investing transactions:
Unpaid issuance costs in accounts payable and accrued expenses	25,674
Modification of right-of-use asset and associated lease liability		97,536
Purchased property and equipment in accounts payable	$ 14,800	$ 50,646